Tempest Therapeutics Inc (NASDAQ: TPST): A Competitive Analysis And Growth Prospects


In the last trading session, 16.65 million shares of the Tempest Therapeutics Inc (NASDAQ:TPST) were traded, and its beta was -1.74. Most recently the company’s share price was $5.44, and it changed around $1.53 or 39.13% from the last close, which brings the market valuation of the company to $120.71M. TPST currently trades at a discount to its 52-week high of $9.77, offering almost -79.6% off that amount. The share price’s 52-week low was $0.17, which indicates that the current value has risen by an impressive 96.88% since then. We note from Tempest Therapeutics Inc’s average daily trading volume that its 10-day average is 0.64 million shares, with the 3-month average coming to 683.96K.

Tempest Therapeutics Inc (NASDAQ:TPST) trade information

Instantly TPST has showed a green trend with a performance of 39.13% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently up 23.64% year-to-date, but still up 49.45% over the last five days. On the other hand, Tempest Therapeutics Inc (NASDAQ:TPST) is 46.63% up in the 30-day period. We can see from the shorts that 0.77 million shares have been sold at a short interest cover period of 1.37 day(s).

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Tempest Therapeutics Inc (TPST) estimates and forecasts

Tempest Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 1523.88 percent over the past six months and at a 18.32% annual growth rate that is well above the industry average of 8.20%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 32.70% in revenue this quarter, and will report an increase of 33.30% in the next quarter.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 62.66%.

TPST Dividends

Tempest Therapeutics Inc’s next quarterly earnings report is expected to be released around March 20 and March 25.

Tempest Therapeutics Inc (NASDAQ:TPST)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 3.16% of Tempest Therapeutics Inc shares, and 29.33% of them are in the hands of institutional investors. The stock currently has a share float of 30.28%. Tempest Therapeutics Inc stock is held by 34 institutions, with EcoR1 Capital, LLC being the largest institutional investor. By Jun 29, 2023, it held 8.43% of the shares, which is about 1.12 million shares worth $1.43 million.

FMR, LLC, with 4.86% or 0.65 million shares worth $0.82 million as of Jun 29, 2023, holds the second largest percentage of outstanding shares.

Vanguard Extended Market Index Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Jun 29, 2023. The former held 0.15 million shares worth $0.2 million, making up 1.16% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 0.15 million shares worth around $0.19 million, which represents about 1.10% of the total shares outstanding.